CTGF

CTGF 분자 정보

영어 이름Connective tissue growth factor시판 약물 수1
임상 약물 수5표적 별명Cellular communication network factor 2,IBP-8,Hypertrophic chondrocyte-specific protein 24,IGF-binding protein 8,IGFBP-8,Connective tissue growth factor,IGFBP8,CCN2,Insulin-like growth factor-binding protein 8,HCS24,CCN family member 2,CTGF,NOV2
최고 연구 개발 단계Approved
영어 이름Connective tissue growth factor
표적 별명Cellular communication network factor 2,IBP-8,Hypertrophic chondrocyte-specific protein 24,IGF-binding protein 8,IGFBP-8,Connective tissue growth factor,IGFBP8,CCN2,Insulin-like growth factor-binding protein 8,HCS24,CCN family member 2,CTGF,NOV2
시판 약물 수1
임상 약물 수5
최고 연구 개발 단계Approved

CTGF 제품 목록

  • 속성

    Protein (5)

  • 제품 라이브러리

    온라인 (5)

  • Human (3)Mouse (1)Rhesus macaque (1)

  • 태그

    His Tag & Avi Tag (1)His Tag (3)Fc Tag (1)

  • 마커

    Biotin-labeled (1)Unconjugated (4)

CTGF분자 배경

Connective Tissue Growth Factor (CTGF), also known as CCN2, is a member of the CCN (CCN1-6) family of modular matricellular proteins. Like other CCN proteins, mature human CTGF consists of IGF-binding protein domain, a vWF-C domain, a TSP-1 domain, and a cysteine knot heparin-binding domain. CTGF promotes proliferation and differentiation of chondrocytes. Mediates heparin- and divalent cation-dependent cell adhesion in many cell types including fibroblasts, myofibroblasts, endothelial and epithelial cells. Enhances fibroblast growth factor-induced DNA synthesis. Analysis of CCN2 function in vivo has focused primarily on its key role as a mediator of excess ECM synthesis in multiple fibrotic diseases.

CTGF분자 별명

CCN2,NOV2,HCS24,IGFBP8,IBP-8,IGFBP-8,IGF-binding protein 8

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
PamrevlumabFG-3019Phase 3 ClinicalFibrogen IncCoronavirus Disease 2019 (COVID-19); Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerulosclerosis, Focal Segmental; Idiopathic Pulmonary Fibrosis; Liver Cirrhosis; Muscular Dystrophy, Duchenne; Pancreatic Neoplasms
상세
OLX-10010cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101Phase 2 ClinicalOlix Pharmaceuticals IncCicatrix, Hypertrophic; Macular Degeneration; Pulmonary Fibrosis; Wet Macular Degeneration
상세
SHR-1906SHR-1906Phase 2 ClinicalGuangdong Hengrui Pharmaceutical Co LtdIdiopathic Pulmonary Fibrosis
상세
PRS-220PRS-220Phase 1 ClinicalPieris PharmaceuticalsIdiopathic Pulmonary Fibrosis
상세
LEM-S401LEM-S401; LEMS401Phase 1 ClinicalLemonex IncCicatrix
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
PenicillamineApprovedValeantDistamine, Pemine, Trisorcin, Cuprimine, Cupramine, TrolovolUnited StatesArthritis, Rheumatoid; Hepatolenticular Degeneration; CystinuriaBausch Health Companies Inc1970-12-04Arthritis, Rheumatoid; Cystinuria; Heavy Metal Poisoning; Hepatolenticular Degeneration; Lead Poisoning
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호